Find Oxyfedrine Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 16777-42-7, Oxyfedrine hcl, Ildamen, Modacor, L-oxyfedrine hydrochloride, Oxyfedrine l-form hydrochloride
Molecular Formula
C19H24ClNO3
Molecular Weight
349.8  g/mol
InChI Key
JMUPNNYLJGSMPK-JPJJPTBZSA-N
FDA UNII
63CF9XK7DA

Oxyfedrine Hydrochloride
A drug used in the treatment of angina pectoris, heart failure, conduction defects, and myocardial infarction. It is a partial agonist at beta adrenergic receptors and acts as a coronary vasodilator and cardiotonic agent.
1 2D Structure

Oxyfedrine Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[[(1R,2S)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-(3-methoxyphenyl)propan-1-one;hydrochloride
2.1.2 InChI
InChI=1S/C19H23NO3.ClH/c1-14(19(22)15-7-4-3-5-8-15)20-12-11-18(21)16-9-6-10-17(13-16)23-2;/h3-10,13-14,19-20,22H,11-12H2,1-2H3;1H/t14-,19-;/m0./s1
2.1.3 InChI Key
JMUPNNYLJGSMPK-JPJJPTBZSA-N
2.1.4 Canonical SMILES
CC(C(C1=CC=CC=C1)O)NCCC(=O)C2=CC(=CC=C2)OC.Cl
2.1.5 Isomeric SMILES
C[C@@H]([C@@H](C1=CC=CC=C1)O)NCCC(=O)C2=CC(=CC=C2)OC.Cl
2.2 Other Identifiers
2.2.1 UNII
63CF9XK7DA
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ildamen

2. Myofedrin

3. Oxifedrine

4. Oxiphedrin

5. Oxyfedrine

6. Oxyphedrin

2.3.2 Depositor-Supplied Synonyms

1. 16777-42-7

2. Oxyfedrine Hcl

3. Ildamen

4. Modacor

5. L-oxyfedrine Hydrochloride

6. Oxyfedrine L-form Hydrochloride

7. Oxyfedrine Hydrochloride, Dl-

8. 63cf9xk7da

9. H1cac99b4d

10. 14223-94-0

11. Oxyfedrine L-form Hcl

12. Oxyfedrin

13. Dsstox_cid_28558

14. Dsstox_rid_82830

15. Dsstox_gsid_48632

16. 3-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-(3-methoxyphenyl)propan-1-one;hydrochloride

17. Oxyfedrine Hydrochloride (jan)

18. Oxyfedrine Hydrochloride [jan]

19. Myophedrine

20. D,l-oxyphedrine

21. 1-propanone, 3-[[(1s,2r)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-(3-methoxyphenyl)-, Hydrochloride (1:1)

22. Cas-16777-42-7

23. Dl-oxyfedrine Hydrochloride

24. Fda 1576

25. Ncgc00182060-02

26. Einecs 240-828-1

27. Unii-h1cac99b4d

28. Oxyfedrine Dl-form Hydrochloride

29. D563

30. D 563

31. Propiophenone, 3-((beta-hydroxy-alpha-methylphenethyl)amino)-3'-methoxy-, Hydrochloride, D,l-

32. 1-propanone, 3-(((1s,2r)-2-hydroxy-1-methyl-2-phenylethyl)amino)-1-(3-methoxyphenyl)-, Hydrochloride (1:1)

33. Ildamen (tn)

34. Unii-63cf9xk7da

35. L-3-methoxy-omega-(1-hydroxy-1-phenylisopropylamino)propiophenone Hydrochloride

36. 1-propanone, 3-((2-hydroxy-1-methyl-2-phenylethyl)amino)-1-(3-methoxyphenyl)-, Hcl, L-

37. L-(1-hydroxy-1-phenyl-2-propylamino)-1-(m-methoxyphenyl)-1-propanone Hydrochloride

38. L-3-(beta-hydroxy-alpha-methyl-phenethylamino)-3'-methoxypropiophenone, Hydrochloride

39. Schembl209076

40. Chembl2354521

41. Dtxsid0048632

42. Fda-1576

43. Tox21_112976

44. Akos037653995

45. Tox21_112976_1

46. Ks-1460

47. 1-propanone, 3-((2-hydroxy-1-methyl-2-phenylethyl)amino)-1-(3-methoxyphenyl)-, Hcl, D,l-

48. D,l-3-(beta-hydroxy-alpha-methyl-phenethylamino)-3'-methoxypropiophenone, Hydrochloride

49. Oxyfedrine Hydrochloride [mart.]

50. Oxyfedrine Hydrochloride, (-)-

51. Propiophenone, 3-((beta-hydroxy-alpha-methylphenethyl)amino)-3'-methoxy-, Hydrochloride, (-)-

52. Ncgc00182060-03

53. Oxyfedrine Hydrochloride [who-dd]

54. (r*,s*)-(+-)-3-((2-hydroxy-1-methyl-2-phenethyl)amino)-1-(3-methoxyphenyl)-1-propanone Hydrochloride

55. (r-(r*,s*))-3-((2-hydroxy-1-methyl-2-phenylethyl)amino)-3'-methoxypropiophenone Hydrochloride

56. 1-propanone, 3-((2-hydroxy-1-methyl-2-phenethyl)amino)-1-(3-methoxyphenyl)-, Hcl, (r*,s*)-

57. D-563

58. Oxyfedrine Dl-form Hydrochloride [mi]

59. Oxyfedrine L-form Hydrochloride [mi]

60. D01233

61. A810903

62. 1-(3-methoxyphenyl)-3-[[(1r,2s)-1-oxidanyl-1-phenyl-propan-2-yl]amino]propan-1-one Hydrochloride

63. 1-propanone, 3-(((1r,2s)-2-hydroxy-1-methyl-2-phenylethyl)amino)-1-(3-methoxyphenyl)-, Hydrochloride (1:1), Rel-

64. 1-propanone, 3-((2-hydroxy-1-methyl-2-phenethyl)amino)-1-(3-methoxyphenyl)-, Hydrochloride, (r*,s*)-(+-)-

65. 3-(((.alpha.s,.beta.r)-.beta.-hydroxy-.alpha.-methylphenethyl)amino)-3'-methoxypropiophenone Hydrochloride

66. 3-((1r,2s)-1-hydroxy-1-phenylpropan-2-ylamino)-1-(3-methoxyphenyl)propan-1-one Hydrochloride

67. 3-[[(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-(3-methoxyphenyl)-1-propanone Hydrochloride

68. Propiophenone, 3-((.beta.-hydroxy-.alpha.-methylphenethyl)amino)-3'-methoxy-, Hydrochloride, (-)-

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 349.8 g/mol
Molecular Formula C19H24ClNO3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count8
Exact Mass349.1444713 g/mol
Monoisotopic Mass349.1444713 g/mol
Topological Polar Surface Area58.6 Ų
Heavy Atom Count24
Formal Charge0
Complexity355
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Adrenergic beta-Agonists

Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)


Cardiotonic Agents

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)


Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty